Bioventus, Inc. (BVS)
12.66
-0.54
(-4.13%)
USD |
NASDAQ |
Sep 17, 16:00
12.66
0.00 (0.00%)
After-Hours: 20:00
Bioventus Enterprise Value : 1.184B for Sept. 16, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 16, 2026 | 1.184B |
| September 15, 2026 | 1.170B |
| September 14, 2026 | 1.181B |
| September 11, 2026 | 1.169B |
| September 10, 2026 | 1.174B |
| September 09, 2026 | 1.213B |
| September 08, 2026 | 1.227B |
| September 04, 2026 | 1.243B |
| September 03, 2026 | 1.263B |
| September 02, 2026 | 1.264B |
| September 01, 2026 | 1.216B |
| August 31, 2026 | 1.214B |
| August 28, 2026 | 1.227B |
| August 27, 2026 | 1.224B |
| August 26, 2026 | 1.236B |
| August 25, 2026 | 1.244B |
| August 24, 2026 | 1.240B |
| August 21, 2026 | 1.264B |
| August 20, 2026 | 1.261B |
| August 19, 2026 | 1.285B |
| August 18, 2026 | 1.259B |
| August 17, 2026 | 1.230B |
| August 14, 2026 | 1.256B |
| August 13, 2026 | 1.231B |
| August 12, 2026 | 1.233B |
| Date | Value |
|---|---|
| August 11, 2026 | 1.228B |
| August 10, 2026 | 1.236B |
| August 07, 2026 | 1.247B |
| August 06, 2026 | 1.237B |
| August 05, 2026 | 1.324B |
| August 04, 2026 | 1.199B |
| August 03, 2026 | 1.202B |
| July 31, 2026 | 1.182B |
| July 30, 2026 | 1.182B |
| July 29, 2026 | 1.178B |
| July 28, 2026 | 1.184B |
| July 27, 2026 | 1.133B |
| July 24, 2026 | 1.088B |
| July 23, 2026 | 1.066B |
| July 22, 2026 | 1.077B |
| July 21, 2026 | 1.094B |
| July 20, 2026 | 1.073B |
| July 17, 2026 | 1.106B |
| July 16, 2026 | 1.131B |
| July 15, 2026 | 1.100B |
| July 14, 2026 | 1.072B |
| July 13, 2026 | 1.107B |
| July 10, 2026 | 1.094B |
| July 09, 2026 | 1.117B |
| July 08, 2026 | 1.109B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Accuray, Inc. | 174.31M |
| Micron Solutions, Inc. | -- |
| Orthofix Medical, Inc. | 519.99M |
| ResMed, Inc. | 32.28B |
| Rockwell Medical, Inc. | 20.12M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 36.20M |
| Revenue (Quarterly) | 153.21M |
| Total Expenses (Quarterly) | 119.77M |
| EPS Diluted (Quarterly) | 0.4721 |
| Gross Profit Margin (Quarterly) | 68.29% |
| Profit Margin (Quarterly) | 23.63% |
| Earnings Yield | 6.13% |
| Operating Earnings Yield | 6.96% |
| Normalized Earnings Yield | 6.399 |